GPNMB was discovered in 1995 by Weterman et al. [19], which is a type I transmembrane glycoprotein, and forms a new signal transduction pathway with Melanocyte Inducing Transcription Factor (MITF), and might promote the development of human cancer. Here, GPNMB is linked to cancer.